[DOI] [PMC free article] [PubMed] [Google Scholar] Svje F, Higgins MJ, Sekhon JS
Your metabolic starting point: Someone with insulin resistance or metabolic syndrome will often see results faster than someone whos metabolically healthy and just trying to lose a modest amount of weight
Figure 1 4 Evidence framework and phenotypic heterogeneity of GLP-1RA-associated taste-related changes In real-world obesity treatment, some patients receiving GLP-1RAs report changes in eating experience, such as food tastes different, food is no longer appealing, or the emergence of unpleasant taste sensations (66) to broader concepts such as food taste change or patient-reported alterations in flavour evaluation (67)
They also had lower triglycerides, lower low-density lipoprotein cholesterol, higher high-density lipoprotein cholesterol, and lower HbA1c levels
Liu N, Wang LH, Guo LL, Wang GQ, Zhou XP, Jiang Y
Its long half-life supports a single weekly subcutaneous injection, while a stepwise titration lets the body adjust and keeps gastrointestinal effects manageable from the first dose
